Showing results (341-350 of 1,120) with videos related to
Sort By:
Pageof 112
Journal of the American Heart Association|August 18, 2020
Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-AnalysisDavide Capodanno, Marco Di Maio, Antonio Greco, et al.Journal of Dairy Science|May 25, 2011
Risk factors associated with selected indicators of milk quality in semiarid northeastern BrazilC J B Oliveira, W D Lopes Júnior, R C R E Queiroga, et al.The American Journal of Cardiology|December 4, 2010
Impact of recovery of renal function on long-term mortality after coronary artery bypass graftingRajendra H Mehta, Emily Honeycutt, Uptal D Patel, et al.American Heart Journal|June 2, 2015
Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trialPaul W Armstrong, Yinggan Zheng, Cynthia M Westerhout, et al.Amino Acids|October 26, 2012
Short peptide constructs mimic agonist sites of AT(1)R and BK receptorsDouglas D Lopes, Renata F F Vieira, Luciana Malavolta, et al.Clinical Cardiology|June 18, 2022
Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitorsBenjamin M Scirica, KyungAh Im, Sabina A Murphy, et al.Journal of the American Heart Association|March 26, 2024
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE TrialKonstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, et al.European Heart Journal|April 14, 2016
The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trialRoopinder K Sandhu, Justin Ezekowitz, Ulrika Andersson, et al.American Heart Journal|October 17, 2012
Red versus white thrombi in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: clinical and angiographic outcomesAlexandre S Quadros, Eduardo Cambruzzi, Juliana Sebben, et al.Journal of the American College of Cardiology|February 7, 2025
Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUSManasi Tannu, Renato D Lopes, Daniel M Wojdyla, et al.Pageof 112